CN103897998A - Lactobacillus salivarius, applications thereof, functional food compositions and preparation method of the functional food composition - Google Patents
Lactobacillus salivarius, applications thereof, functional food compositions and preparation method of the functional food composition Download PDFInfo
- Publication number
- CN103897998A CN103897998A CN201210572842.5A CN201210572842A CN103897998A CN 103897998 A CN103897998 A CN 103897998A CN 201210572842 A CN201210572842 A CN 201210572842A CN 103897998 A CN103897998 A CN 103897998A
- Authority
- CN
- China
- Prior art keywords
- lactobacillus salivarius
- functional food
- food composition
- nematode
- brain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000186869 Lactobacillus salivarius Species 0.000 title claims abstract description 120
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 235000013376 functional food Nutrition 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241000894006 Bacteria Species 0.000 claims abstract description 65
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 42
- 238000000034 method Methods 0.000 claims description 37
- 230000009849 deactivation Effects 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 27
- 230000001934 delay Effects 0.000 claims description 23
- 235000013305 food Nutrition 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 abstract description 11
- 230000003712 anti-aging effect Effects 0.000 abstract description 9
- 239000000126 substance Substances 0.000 abstract description 3
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 94
- 241000244206 Nematoda Species 0.000 description 62
- 210000004556 brain Anatomy 0.000 description 57
- 235000015097 nutrients Nutrition 0.000 description 28
- 239000011734 sodium Substances 0.000 description 24
- 239000000243 solution Substances 0.000 description 24
- 102000010909 Monoamine Oxidase Human genes 0.000 description 22
- 108010062431 Monoamine oxidase Proteins 0.000 description 22
- 241000699670 Mus sp. Species 0.000 description 21
- 230000000968 intestinal effect Effects 0.000 description 21
- 230000000052 comparative effect Effects 0.000 description 18
- 239000006228 supernatant Substances 0.000 description 17
- 239000008399 tap water Substances 0.000 description 17
- 235000020679 tap water Nutrition 0.000 description 17
- 239000007788 liquid Substances 0.000 description 15
- 239000012530 fluid Substances 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 12
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 12
- 238000013016 damping Methods 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 230000034994 death Effects 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000032683 aging Effects 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 239000006166 lysate Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 102000002322 Egg Proteins Human genes 0.000 description 6
- 108010000912 Egg Proteins Proteins 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 239000002054 inoculum Substances 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 210000004681 ovum Anatomy 0.000 description 6
- 229910052697 platinum Inorganic materials 0.000 description 6
- 238000007789 sealing Methods 0.000 description 6
- 239000010902 straw Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 239000006041 probiotic Substances 0.000 description 4
- 230000000529 probiotic effect Effects 0.000 description 4
- 235000018291 probiotics Nutrition 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 239000002028 Biomass Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 230000012447 hatching Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000244203 Caenorhabditis elegans Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- -1 lipid peroxide Chemical class 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000008057 potassium phosphate buffer Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- ZESRJSPZRDMNHY-YFWFAHHUSA-N 11-deoxycorticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 ZESRJSPZRDMNHY-YFWFAHHUSA-N 0.000 description 1
- 108010023063 Bacto-peptone Proteins 0.000 description 1
- 241000244202 Caenorhabditis Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- RTYJTGSCYUUYAL-YCAHSCEMSA-L carbenicillin disodium Chemical compound [Na+].[Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)C(C([O-])=O)C1=CC=CC=C1 RTYJTGSCYUUYAL-YCAHSCEMSA-L 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 229960003654 desoxycortone Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- ODKNJVUHOIMIIZ-RRKCRQDMSA-N floxuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 235000021581 juice product Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- ZHNFLHYOFXQIOW-LPYZJUEESA-N quinine sulfate dihydrate Chemical compound [H+].[H+].O.O.[O-]S([O-])(=O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 ZHNFLHYOFXQIOW-LPYZJUEESA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940032362 superoxide dismutase Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 108010046845 tryptones Proteins 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention provides lactobacillus salivarius. The lactobacillus salivarius is characterized in that the accession number of lactobacillus salivarius is CGMCC No.6288. The invention also provides a functional food composition and a preparation method thereof. The preparation method of the functional food composition includes inactivating living bacteria of the lactobacillus salivarius to obtain a bacterial substance. The invention also provides a functional food composition comprising the living bacteria of the lactobacillus salivarius. The invention also provides applications of the lactobacillus salivarius in preparation of the anti-ageing functional food compositions. The living bacteria of the lactobacillus salivarius and the inactivated bacterial substance both have anti-aging functions.
Description
Technical field
The present invention relates to lactobacillus salivarius (Lactobacillus salivarius) and application and functional food composition and preparation method thereof, particularly, relate to a kind of lactobacillus salivarius, contain functional food composition of this lactobacillus salivarius and preparation method thereof, and application in the functional food that delays senility in preparation of this lactobacillus salivarius.
Background technology
Aging is that the degeneration that body tissue, organ dysfunction occur with age growth changes (Turnheim, 2003), is the general performance of the various biochemical reactions of body.Economic fast development, the progress of science and technology, makes developed country and some developing countries step into aging society.The problem of an aging population has become global social concern.By the end of the year 2009, China 60 years old and above elderly population reach 1.6714 hundred million, account for 12.5% of total population, expect the year two thousand twenty and will reach 2.43 hundred million.With advancing age and the aging of body, the disease relevant to aging, as cardiovascular, nervous system disorders, tumour, diabetes etc., the life-span and the quality of life that are threatening the mankind.Therefore, increasing research is absorbed in to find and is had the material of anti-aging effects and study its anti-ageing mechanism.Current multiple natural product has been proved has anti-aging effects.But the Material Source with anti-aging effects of thinking is at present comparatively single, and separation and purification cost is high, the medicine with anti-aging effects has again certain side effect, thereby has limited the widespread adoption of these materials.Probiotic bacterium security is higher, and separation and purification cost is low, if can specify the antisenility function of probiotic bacterium, and determines its mechanism of resisting senility, and the prospect using probiotic bacterium as anti-aging product will be very wide.
Lactobacillus salivarius is the Bacterium lacticum extensively existing in human body and animal body.In the oral cavity of human body, breast milk, woman vagina, can detect lactobacillus salivarius (the few equality of Lee, 1991; Olivares et al., 2006).It is the ancestral home bacterium of human body, is one of normal microflora being present in human body; Except human body, from the enteron aisles such as chicken, pig, rabbit, be also separated to lactobacillus salivarius (Chen Guiyin, 2006; Tang Xiaoli, 2007; Luo Rui, 2011).And lactobacillus salivarius do not belong to common pathogenic bacterium, seldom there is the diseases induced report of lactobacillus salivarius, the lactobacillus salivarius strains that therefore a lot of research all obtains screening carry out functional study, use to the probiotic bacterium as human and animal.
Summary of the invention
The object of this invention is to provide a kind of lactobacillus salivarius with deferring senility.
To achieve these goals, on the one hand, the invention provides a kind of lactobacillus salivarius (Lactobacillus salivarius), it is characterized in that, the deposit number of described lactobacillus salivarius is CGMCC No.6288.
Second aspect, the invention provides a kind of method of preparing functional food composition, and described method comprises: by the viable bacteria body deactivation of lactobacillus salivarius as above, obtain thalline material.
The third aspect, the invention provides a kind of functional food composition of being prepared by method as above.
Fourth aspect, the invention provides a kind of functional food composition, it is characterized in that, the viable bacteria body that described functional food composition contains lactobacillus salivarius as above.
The 5th aspect, the invention provides the application in the functional food composition that lactobacillus salivarius as above delays senility in preparation.
Thalline material after viable bacteria body and the deactivation of lactobacillus salivarius provided by the invention all has the effect delaying senility.
Other features and advantages of the present invention are described in detail the embodiment part subsequently.
Biological preservation
Lactobacillus salivarius of the present invention (Lactobacillus salivarius), be deposited in (address: No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, China Committee for Culture Collection of Microorganisms's common micro-organisms center on June 25th, 2012, Institute of Microorganism, Academia Sinica, postcode: 100101) (depositary institution be abbreviated as CGMCC), deposit number is CGMCC No.6288.
Embodiment
Below the specific embodiment of the present invention is elaborated.Should be understood that, embodiment described herein only, for description and interpretation the present invention, is not limited to the present invention.
On the one hand, the invention provides a kind of lactobacillus salivarius (Lactobacillus salivarius), the deposit number of this lactobacillus salivarius is CGMCC No.6288.
Lactobacillus salivarius of the present invention separates the ight soil from Bama County of Guangxi long lived elder.
Lactobacillus salivarius provided by the invention is through cultivating the viable bacteria body that can produce a large amount of lactobacillus salivarius, and the method for described cultivation does not have special requirement, as long as making described lactobacillus salivarius propagation, and for example can be by 10
7the inoculation of magnitude is in Bacterium lacticum substratum, and under anaerobism or aerobic condition, cultivates after 8-72 hour at the temperature of 15-38 DEG C, obtains nutrient solution.Described Bacterium lacticum substratum can be the substratum that known various applicable Bacterium lacticum is cultivated, can be for example milk and/or " milk-acid bacteria---Basic of Biology and application " (Yang Jiebin, light industry press, 1996 publish) described in milk-acid bacteria (MRS) substratum.
The present invention can further separate the viable bacteria body of the lactobacillus salivarius in above-mentioned nutrient solution, the method of described separation has no particular limits, as long as can be from nutrient solution enrichment thalline, for example can realize by method centrifugal and/or that filter, described condition centrifugal and described filtration can be known condition, and the present invention does not repeat them here.
Second aspect, the invention provides a kind of method of preparing functional food composition, and described method comprises: by the viable bacteria body deactivation of lactobacillus salivarius as above, obtain thalline material.
The present inventor is surprisingly discovery under study for action, and the thalline material obtaining after deactivation 0.5-1.5h at 65-85 DEG C, has the effect delaying senility more significantly.Therefore, the condition optimization of deactivation comprises: temperature is 65-85 DEG C, and the time is 0.5-1.5h.
The inventive method also comprises adds thalline material in food to.
According to the present invention, although thalline material is added in food, can realize object of the present invention, play the effect delaying senility, but under preferable case, taking the gross weight of functional food composition as benchmark, the addition of thalline material is 10-70 % by weight, more preferably 30-50 % by weight.Under above-mentioned preferable case, the effect delaying senility of functional food composition is more remarkable.
In the present invention, food can be the food of any type, such as juice product, milk-product, bean product etc.Food also can be according to the difference of edible object and different.In described functional food composition, can also contain conventional additive, such as spices, mineral substance, VITAMIN, stablizer, thickening material, sanitas etc.
The third aspect, the invention provides a kind of functional food composition of being prepared by method as above.
Fourth aspect, the invention provides a kind of functional food composition, the viable bacteria body that this functional food composition contains lactobacillus salivarius as above.
According to the present invention, although the viable bacteria body that functional food composition contains lactobacillus salivarius as above can be realized object of the present invention, play the effect delaying senility.But under preferable case, taking the gross weight of functional food composition as benchmark, the content of the viable bacteria body of lactobacillus salivarius is 10
5-10
10cFU/g, more preferably 10
7-10
9cFU/g.Under above-mentioned preferable case, the effect delaying senility of functional food composition is more remarkable.
The viable bacteria body of the lactobacillus salivarius that the functional food composition that meets above-mentioned requirements can comprise the nutrient solution of lactobacillus salivarius (for example through this lactobacillus salivarius ferment the cultured milk prod making), separate etc.
In the present invention, functional food composition also contains food, and food as previously mentioned, does not repeat them here.
The 5th aspect, the invention provides the application in the functional food composition that lactobacillus salivarius as above delays senility in preparation.
More than describe the preferred embodiment of the present invention in detail; but the present invention is not limited to the detail in above-mentioned embodiment, within the scope of technical conceive of the present invention; can carry out multiple simple variant to technical scheme of the present invention, these simple variant all belong to protection scope of the present invention.
It should be noted that in addition, each concrete technical characterictic described in above-mentioned embodiment, in reconcilable situation, can combine by any suitable mode, for fear of unnecessary repetition, the present invention is to the explanation no longer separately of various possible array modes.
In addition, also can carry out arbitrary combination between various embodiment of the present invention, as long as it is without prejudice to thought of the present invention, it should be considered as content disclosed in this invention equally.
Embodiment
The present invention is further illustrated for following embodiment, but therefore do not limit the present invention.
(1) adopt nematode as study subject
Nematode is growth, apoptosis, old and feeble area research model animals the most clearly, its life cycle is short, and environment sensitive to external world, and because the homology of old and feeble signal is high, the research of unicellular lower eukaryote has direct reference (Greer and Brunet, 2008) to Mammals and human senility.Therefore, adopt in the following Examples and Comparative Examples nematode as study subject.
In following embodiment and comparative example:
Nematode is the strain of Caenorhabditis elegans worm, and wild-type Caenorhabditis elegans N2, purchased from U.S.'s nematode genetics center (Caenorhabditis Genetics Center(CGC)).
Bacterial classification: nematode standard food intestinal bacteria (E.coli) OP50, purchased from U.S.'s nematode genetics center; Lactobacillus salivarius A is that (this bacterial strain was deposited in (address: No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, China Committee for Culture Collection of Microorganisms's common micro-organisms center to lactobacillus salivarius of the present invention on June 25th, 2012, Institute of Microorganism, Academia Sinica, postcode: 100101) (depositary institution be abbreviated as CGMCC), deposit number is CGMCC No.6288).
Nematode elementary operation method is carried out with reference to Wormbook standard eelworm culture method.
1M potassium phosphate buffer (pH 6.0): 108.3g KH
2pO
4, 46.8g K
2hPO
43H
2o, distilled water is settled to 1L, and 121 DEG C of sterilizing 15min are for subsequent use.
NGM substratum: 3.0g NaCl, 20g agar powder, 2.5g bacto peptone, adds distilled water 970mL, and 121 DEG C of sterilizing 15min are placed in 60 DEG C of water-baths, add following composition under aseptic condition: 1mL 1M MgSO
4, 1mL 1M CaCl
2, 25mL 1M potassium phosphate buffer, the ethanolic soln of 3.2mL 5mg/mL cholesterol; After mixing, pour plate.After flat board solidifies, be placed in room temperature 2 days, volatilization moisture and inspection are dull and stereotyped to be placed in 4 DEG C of watertight chests and to save backup without living contaminants.
MNGM substratum: add FUdR, Pyocianil to the final concentration of degerming to be after filtration respectively 50 μ M, 0.5mM under aseptic condition before NGM substratum pour plate, mix pour plate, solidify and be placed on 2 days volatilization moisture of room temperature, flat board can be coated with bacterium and use or be placed in preservation in 4 DEG C of watertight chests afterwards, in 1 month, finishes using.
M9 damping fluid: 3g KH
2pO
4, 15.12g Na
2hPO
412H
2o, 5g NaCl, adding distil water is settled to 1L, and 121 DEG C of sterilizing 15min are cooled to the aseptic 1mL of adding 1M MgSO after room temperature
4, mix for subsequent use.
Nematode lysate: 1mL 8M NaOH, 0.6mL 9% chlorine bleach liquor, the aseptic ddH of 3.4mL
2o, mixes rear use, matching while using.
LB substratum: Tryptones 10g, yeast soaks powder 5g, NaCl 10g(solid medium adds 15g agar), add 950mL distilled water, regulate pH to 7.0,121 DEG C of sterilizing 15min are for subsequent use.
MRS substratum: be purchased from Beijing overpass company.
Embodiment 1.1
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
(1) intestinal bacteria OP50 is seeded to LB liquid nutrient medium with 1% inoculum size, in 37 DEG C of 220rpm shaking culture 8h of constant-temperature table to logarithm latter stage, obtains intestinal bacteria OP50 nutrient solution; Lactobacillus salivarius A is seeded to MRS liquid nutrient medium with 1% inoculum size, cultivates 12h to logarithm latter stage in filling 37 DEG C, nitrogen anaerobism bottle, obtain lactobacillus salivarius A nutrient solution.
By the nutrient solution of above-mentioned intestinal bacteria OP50 and lactobacillus salivarius A, collect thalline with the centrifugal 15min of 4000 × g respectively, by M9 damping fluid repeated centrifugation washed twice, 4 DEG C of centrifugal 15min of 16000 × g, remove whole supernatant liquors afterwards, weigh thalline weight in wet base.Thalline is resuspended with a certain amount of M9, and making thalline final concentration is 400mg/mL, is sub-packed in 1.5mL centrifuge tube, as concentrated thalline.
Respectively by 75 DEG C of hot deactivation 1h of above-mentioned two kinds of concentrated thalline, after cooling, intestinal bacteria OP50 and lactobacillus salivarius A are mixed to get to mixture by the weight ratio of 3:2 (being that lactobacillus salivarius is 40 % by weight), mixture is suspended in M9 damping fluid according to the ratio of 400mg/mL, coat the mNGM planar surface of diameter 60mm, making every dull and stereotyped biomass is 10mg, totally 6 flat boards, 4 DEG C of sealings save backup.
(2) in diameter 90mm NGM media surface, be evenly coated with 200 μ L intestinal bacteria OP50 nutrient solutions, cultivate 10h for 37 DEG C, to go down to posterity with dull and stereotyped as nematode, 4 DEG C of sealings save backup.
Under aseptic condition, there is the NGM flat board of nematode to cut the fritter substratum of about 1cm × 1cm from growth with scalpel, facing down is buckled in nematode and goes down to posterity with dull and stereotyped upper, is placed in 25 DEG C of cultivations, and 60mm plate goes down to posterity once for general 7 days, keeps nematode activity.
Get after going down to posterity adult mostly the flat board in the spawning time for nematode synchronization:
In flat board, add 2mL M9 damping fluid, with aseptic straw piping and druming, sweep away the polypide on flat board as far as possible, polypide is transferred to 1.5mL centrifuge tube, the centrifugal 1min of 800 × g, abandons supernatant and collects polypide, adds 1mL M9 recentrifuge washing polypide, exhausts supernatant as far as possible.
Add the nematode lysate that 1mL is fresh, vortex oscillation 10s at once, the centrifugal 1min of 800 × g, pipettor siphons away supernatant.
Add at once 1mL M9 washing polypide, the centrifugal 1min of 800 × g, double, remove residual lysate.The M9 suspension liquid that finally in pipe, residue approximately 100 μ L contain worm's ovum.
Use aseptic straw that worm's ovum is dripped in the NGM flat board of coating OP50, cultivate 48h for 25 DEG C, obtain the nematode of synchronization 48h.
(3) by the nematode of synchronization 48h, be placed in stereomicroscope observation, using platinum shovel picking gonotreme is on the mNGM flat board that obtains in step (1) of transparent semi-moon shaped L4 phase telianthus worm, 10 of every dull and stereotyped pickings, and flat board is placed in 25 DEG C of cultivations.Observe nematode survival state every day, as polypide touches and do not have movable reaction to think polypide death platinum shovel.Get rid of hatching and unnatural death nematode in missing, body.All end is tested in nematode death.Calculate nematode mean lifetime in table 1.
Embodiment 1.2
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
(1) intestinal bacteria OP50 is seeded to LB liquid nutrient medium with 1% inoculum size, in 37 DEG C of 220rpm shaking culture 8h of constant-temperature table to logarithm latter stage, obtains intestinal bacteria OP50 nutrient solution; Lactobacillus salivarius A is seeded to MRS liquid nutrient medium with 1% inoculum size, cultivates 12h to logarithm latter stage in filling 37 DEG C, nitrogen anaerobism bottle, obtain lactobacillus salivarius A nutrient solution.
By the nutrient solution of above-mentioned intestinal bacteria OP50 and lactobacillus salivarius A, collect thalline with the centrifugal 15min of 4000 × g respectively, by M9 damping fluid repeated centrifugation washed twice, 4 DEG C of centrifugal 15min of 16000 × g, remove whole supernatant liquors afterwards, weigh thalline weight in wet base.Thalline is resuspended with a certain amount of M9, and making thalline final concentration is 400mg/mL, is sub-packed in 1.5mL centrifuge tube, as concentrated thalline.
Respectively by 65 DEG C of hot deactivation 1.5h of above-mentioned two kinds of concentrated thalline, after cooling, intestinal bacteria OP50 and lactobacillus salivarius A are mixed to get to mixture by the weight ratio of 7:3 (being that lactobacillus salivarius is 30 % by weight), mixture is suspended in M9 damping fluid according to the ratio of 400mg/mL, coat the mNGM planar surface of diameter 60mm, making every dull and stereotyped biomass is 10mg, totally 6 flat boards, 4 DEG C of sealings save backup.
(2) in diameter 90mm NGM media surface, be evenly coated with 200 μ L intestinal bacteria OP50 nutrient solutions, cultivate 10h for 37 DEG C, to go down to posterity with dull and stereotyped as nematode, 4 DEG C of sealings save backup.
Under aseptic condition, there is the NGM flat board of nematode to cut the fritter substratum of about 1cm × 1cm from growth with scalpel, facing down is buckled in nematode and goes down to posterity with dull and stereotyped upper, is placed in 25 DEG C of cultivations, and 60mm plate goes down to posterity once for general 7 days, keeps nematode activity.
Get after going down to posterity adult mostly the flat board in the spawning time for nematode synchronization:
In flat board, add 2mL M9 damping fluid, with aseptic straw piping and druming, sweep away the polypide on flat board as far as possible, polypide is transferred to 1.5mL centrifuge tube, the centrifugal 1min of 800 × g, abandons supernatant and collects polypide, adds 1mL M9 recentrifuge washing polypide, exhausts supernatant as far as possible.
Add the nematode lysate that 1mL is fresh, vortex oscillation 10s at once, the centrifugal 1min of 800 × g, pipettor siphons away supernatant.
Add at once 1mL M9 washing polypide, the centrifugal 1min of 800 × g, double, remove residual lysate.The M9 suspension liquid that finally in pipe, residue approximately 100 μ L contain worm's ovum.
Use aseptic straw that worm's ovum is dripped in the NGM flat board of coating OP50, cultivate 48h for 25 DEG C, obtain the nematode of synchronization 48h.
(3) by the nematode of synchronization 48h, be placed in stereomicroscope observation, using platinum shovel picking gonotreme is on the mNGM flat board that obtains in step (1) of transparent semi-moon shaped L4 phase telianthus worm, 10 of every dull and stereotyped pickings, and flat board is placed in 25 DEG C of cultivations.Observe nematode survival state every day, as polypide touches and do not have movable reaction to think polypide death platinum shovel.Get rid of hatching and unnatural death nematode in missing, body.All end is tested in nematode death.Calculate nematode mean lifetime in table 1.
Embodiment 1.3
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
(1) intestinal bacteria OP50 is seeded to LB liquid nutrient medium with 1% inoculum size, in 37 DEG C of 220rpm shaking culture 8h of constant-temperature table to logarithm latter stage, obtains intestinal bacteria OP50 nutrient solution; Lactobacillus salivarius A is seeded to MRS liquid nutrient medium with 1% inoculum size, cultivates 12h to logarithm latter stage in filling 37 DEG C, nitrogen anaerobism bottle, obtain lactobacillus salivarius A nutrient solution.
By the nutrient solution of above-mentioned intestinal bacteria OP50 and lactobacillus salivarius A, collect thalline with the centrifugal 15min of 4000 × g respectively, by M9 damping fluid repeated centrifugation washed twice, 4 DEG C of centrifugal 15min of 16000 × g, remove whole supernatant liquors afterwards, weigh thalline weight in wet base.Thalline is resuspended with a certain amount of M9, and making thalline final concentration is 400mg/mL, is sub-packed in 1.5mL centrifuge tube, as concentrated thalline.
Respectively by 85 DEG C of hot deactivation 0.5h of above-mentioned two kinds of concentrated thalline, after cooling, intestinal bacteria OP50 and lactobacillus salivarius A are mixed to get to mixture by the weight ratio of 1:1 (being that lactobacillus salivarius is 50 % by weight), mixture is suspended in M9 damping fluid according to the ratio of 400mg/mL, coat the mNGM planar surface of diameter 60mm, making every dull and stereotyped biomass is 10mg, totally 6 flat boards, 4 DEG C of sealings save backup.
(2) in diameter 90mm NGM media surface, be evenly coated with 200 μ L intestinal bacteria OP50 nutrient solutions, cultivate 10h for 37 DEG C, to go down to posterity with dull and stereotyped as nematode, 4 DEG C of sealings save backup.
Under aseptic condition, there is the NGM flat board of nematode to cut the fritter substratum of about 1cm × 1cm from growth with scalpel, facing down is buckled in nematode and goes down to posterity with dull and stereotyped upper, is placed in 25 DEG C of cultivations, and 60mm plate goes down to posterity once for general 7 days, keeps nematode activity.
Get after going down to posterity adult mostly the flat board in the spawning time for nematode synchronization:
In flat board, add 2mL M9 damping fluid, with aseptic straw piping and druming, sweep away the polypide on flat board as far as possible, polypide is transferred to 1.5mL centrifuge tube, the centrifugal 1min of 800 × g, abandons supernatant and collects polypide, adds 1mL M9 recentrifuge washing polypide, exhausts supernatant as far as possible.
Add the nematode lysate that 1mL is fresh, vortex oscillation 10s at once, the centrifugal 1min of 800 × g, pipettor siphons away supernatant.
Add at once 1mL M9 washing polypide, the centrifugal 1min of 800 × g, double, remove residual lysate.The M9 suspension liquid that finally in pipe, residue approximately 100 μ L contain worm's ovum.
Use aseptic straw that worm's ovum is dripped in the NGM flat board of coating OP50, cultivate 48h for 25 DEG C, obtain the nematode of synchronization 48h.
(3) by the nematode of synchronization 48h, be placed in stereomicroscope observation, using platinum shovel picking gonotreme is on the mNGM flat board that obtains in step (1) of transparent semi-moon shaped L4 phase telianthus worm, 10 of every dull and stereotyped pickings, and flat board is placed in 25 DEG C of cultivations.Observe nematode survival state every day, as polypide touches and do not have movable reaction to think polypide death platinum shovel.Get rid of hatching and unnatural death nematode in missing, body.All end is tested in nematode death.Calculate nematode mean lifetime in table 1.
Embodiment 1.4
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
Carry out nematode longevity test according to the method for embodiment 1.1, different, in step (1), after deactivation is cooling, intestinal bacteria OP50 and lactobacillus salivarius A are mixed by the weight ratio of 3:7 (being that lactobacillus salivarius is 70 % by weight).Calculate nematode mean lifetime in table 1.
Embodiment 1.5
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
Carry out nematode longevity test according to the method for embodiment 1.1, different, in step (1), after deactivation is cooling, intestinal bacteria OP50 and lactobacillus salivarius A are mixed by the weight ratio of 9:1 (being that lactobacillus salivarius is 10 % by weight).Calculate nematode mean lifetime in table 1.
Embodiment 1.6
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
Carry out nematode longevity test according to the method for embodiment 1.1, different, deactivation temperature is 90 DEG C, and inactivation time is 0.3h.Calculate nematode mean lifetime in table 1.
Embodiment 1.7
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
Carry out nematode longevity test according to the method for embodiment 1.1, different, deactivation temperature is 60 DEG C, and inactivation time is 2.0h.Calculate nematode mean lifetime in table 1.
Comparative example 1.1
Carry out nematode longevity test according to the method for embodiment 1.1, different, with the alternative lactobacillus salivarius A of the disclosed bacterial strain of CN 101538545A.Calculate nematode mean lifetime in table 1.
Comparative example 1.2
Carry out nematode longevity test according to the method for embodiment 1.1, different, after deactivation is cooling, intestinal bacteria OP50 is suspended in M9 damping fluid according to the ratio of 400mg/mL, coat mNGM planar surface,, mNGM planar surface is only coated with the cooled intestinal bacteria OP50 of deactivation.Calculate nematode mean lifetime in table 1.
Table 1
| Nematode mean lifetime (my god) | |
| Embodiment 1.1 | 24.1±0.4 |
| Embodiment 1.2 | 23.1±0.6 |
| Embodiment 1.3 | 24.3±0.5 |
| Embodiment 1.4 | 18.9±0.4 |
| Embodiment 1.5 | 18.7±0.9 |
| Embodiment 1.6 | 19.1±0.2 |
| Embodiment 1.7 | 20.0±0.3 |
| Comparative example 1.1 | 17.8±0.2 |
| Comparative example 1.2 | 17.2±1.0 |
Embodiment 1.1 is compared and can be found out with comparative example 1.1 and comparative example 1.2 respectively, and lactobacillus salivarius of the present invention has the effect delaying senility, after deactivation for the nematode of feeding, life-span that can significant prolongation nematode.
Embodiment 1.1 is compared and can be found out with embodiment 1.4 and embodiment 1.5 respectively, after deactivation is cooling, intestinal bacteria OP50 and lactobacillus salivarius A are mixed, taking the gross weight of mixture as benchmark, the addition of lactobacillus salivarius A is 30-50 % by weight, more the life-span of significant prolongation nematode; Embodiment 1.1 is compared and can be found out with embodiment 1.6 and embodiment 1.7 respectively, at 65-85 DEG C of deactivation 0.5-1.5h, be more conducive to extend the life-span of nematode.
(2) adopt mouse as study subject
In following embodiment and comparative example:
Male Kunming strain mice: purchased from Beijing company of dimension tonneau China, body weight 20 ± 2g.
Lactobacillus salivarius A is that (this bacterial strain was deposited in (address: No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, China Committee for Culture Collection of Microorganisms's common micro-organisms center to lactobacillus salivarius of the present invention on June 25th, 2012, Institute of Microorganism, Academia Sinica, postcode: 100101) (depositary institution be abbreviated as CGMCC), deposit number is CGMCC No.6288).
MRS substratum: be purchased from Beijing overpass company.
Coomassie brilliant blue G250: be purchased from the biological company limited of Shanghai, Shanghai space.
Iipofuscin content, brain MAO-B activity, brain SOD activity and brain Na
+/ K
+the mensuration of-atpase activity is referring to " anti-aging effects of Water-soluable Polysaccharide from Rhizoma Dioscoreae Opposite on Mice " (Zhan Tong, Tao Jing, Wang Shuru, pharmacy progress, the 6th phase of 23 volumes in 1999):
Iipofuscin assay: get liver, make 5% homogenate with chloroform-methanol mixed solution, 40 DEG C of warm water bath 5 minutes, with 3000rpm centrifugal 10 minutes, to get supernatant liquor and survey fluorescence, emission wavelength is 435nm, excitation wavelength is 365nm, put sensitivity × 1, slit 10nm, regulating instrument fluorescence intensity with the Quinine Sulphate Di HC of 0.1 μ g/mL is 50.
Brain MAO-B(B MAO-B B) determination of activity: get cerebral tissue, add phosphoric acid buffer (the 0.1mol/L K of ice-cold 0.2mol/LpH7.4
2hPO
480.2ml and 0.1mol/L KH
2pO
419.8ml mix), ultrasonic homogenate 2 times, in 4 DEG C with 3000rpm centrifugal 10 minutes, precipitation is suspended in PBS liquid (pH7.4), and water-bath immediately vibration mixes, with 3000rpm centrifugal 10 minutes, cyclohexane layer is surveyed to light absorption value in 242nm place, crude enzyme liquid protein concentration is measured with Coomassie brilliant blue G250, makes standard protein with bSA, and enzyme activity unit is defined as 37 DEG C of enzyme amounts that produce the optical density(OD) change of 0.01/3h.
Brain SOD(superoxide-dismutase) determination of activity: get cerebral tissue, tissue sample is measured the SOD ultramicron Fast Measurement reagent that adopts diease occurrence teaching and research group of Nanjing Railway College of Medicine, enzymic activity represents with U/mg enzyme amount, calculation formula: [(control tube optical density(OD)-mensuration pipe optical density(OD))/control tube optical density(OD)]/50/100 × diluted sample degree/sample protein concentration.Sample protein concentration is measured with Coomassie brilliant blue G250, and calf serum is made standard protein.
Brain Na
+/ K
+-atpase activity is measured: get cerebral tissue 0.1g, add rapidly 1ml extracting solution (to include sucrose 250mmol/L, Histidine 30mmol/L, EDTA 5mmol/L, Desoxycortone 10 % by weight.Ice bath homogenate, three layers of filtered through gauze, obtain crude enzyme liquid, and protein concentration is measured with Coomassie brilliant blue G250.Enzymatic reaction is divided into two groups: A group, adds the medium A TP liquid (MgCl of 0.4mL
26mmol/L, NaCl 100mmol/L, KCl 20mmol/L, Tris 30mmol/L, ATP 3mmol/L).50 μ L dielectric fluid (MgCl
26mmol/L, NaCl 100mmol/L, KCl 20mmol/L, Tris 30mmol/L) and crude enzyme liquid 50 μ L; B group, adds Quabain and suppresses Na
+/ K
+-ATP enzyme, replaces 50 μ L dielectric fluids with the 5mmol/L Quabain of 50 μ L, and all the other are identical.In 37 DEG C of water-baths, react respectively 20 minutes, add 30% ice-cold trichoroacetic acid(TCA) 0.3mL, move in ice bath, with 1500rpm centrifugal 5 minutes, get supernatant liquor 0.5ml, survey its content of inorganic phosphorus.Step is: get 0.5mL and measure liquid, add the 2mL developer (FeSO of 1 volume 10% ammonium molybdate+9 volume freshly prepared 9.15%
47H
2o) and 2mL distilled water mix, 25 DEG C of reactions 8 minutes, survey light absorption value in 652nm place, make typical curve with standard phosphorus solution, try to achieve content of inorganic phosphorus, finally Na
+/ K
+the content of inorganic phosphorus that-ATP enzyme decomposes is the amount of A group-B group.Enzymic activity is expressed as μ mol pi/hrmg albumen, and protein concentration is measured with Coomassie brilliant blue G250, and calf serum is made standard protein.
Embodiment 2.1
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
(1) lactobacillus salivarius A is inoculated in to the MRS substratum of 10L with aseptic inoculation ring, and under anaerobic, at the temperature of 37 DEG C, cultivates after 12 hours, obtain nutrient solution.By the nutrient solution obtaining supernatant discarded after centrifugal 10 minutes under the speed of 4000 × g, obtain the viable bacteria body of lactobacillus salivarius A.
(2) choose immediately 15 Male Kunming strain mice, every day, retrobulbar injection D-semi-lactosi 0.12mg/g, and fed containing 1 × 10
9the tap water of the viable bacteria body of the lactobacillus salivarius A of CFU/g, continuous one month.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Embodiment 2.2
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
(1) lactobacillus salivarius A is inoculated in to the MRS substratum of 10L with aseptic inoculation ring, and under anaerobic, at the temperature of 37 DEG C, cultivates after 12 hours, obtain nutrient solution.By the nutrient solution obtaining supernatant discarded after centrifugal 10 minutes under the speed of 4000 × g, obtain the viable bacteria body of lactobacillus salivarius A.
(2) choose immediately 15 Male Kunming strain mice, every day, retrobulbar injection D-semi-lactosi 0.12mg/g, and fed containing 1 × 10
8the tap water of the viable bacteria body of the lactobacillus salivarius A of CFU/g, continuous one month.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Embodiment 2.3
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
(1) lactobacillus salivarius A is inoculated in to the MRS substratum of 10L with aseptic inoculation ring, and under anaerobic, at the temperature of 37 DEG C, cultivates after 12 hours, obtain nutrient solution.By the nutrient solution obtaining supernatant discarded after centrifugal 10 minutes under the speed of 4000 × g, obtain the viable bacteria body of lactobacillus salivarius A.
(2) choose immediately 15 Male Kunming strain mice, every day, retrobulbar injection D-semi-lactosi 0.12mg/g, and fed containing 1 × 10
7the tap water of the viable bacteria body of the lactobacillus salivarius A of CFU/g, continuous one month.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Embodiment 2.4
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
Method according to embodiment 2.1 is tested, different, and in tap water, the content of the viable bacteria body of lactobacillus salivarius A is 1 × 10
10cFU/g.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Embodiment 2.5
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
Method according to embodiment 2.1 is tested, different, and in tap water, the content of the viable bacteria body of lactobacillus salivarius A is 1 × 10
5cFU/g.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Embodiment 2.6
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
Method according to embodiment 2.1 is tested, different, step (1) is obtained to viable bacteria body hot deactivation 1h at 75 DEG C of lactobacillus salivarius A, obtain thalline material, this thalline material is joined in tap water and do not add viable bacteria body, in tap water, the content of thalline material is 40 % by weight.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Embodiment 2.7
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
Method according to embodiment 2.1 is tested, different, step (1) is obtained to viable bacteria body hot deactivation 1.5h at 65 DEG C of lactobacillus salivarius A, obtain thalline material, this thalline material is joined in tap water and do not add viable bacteria body, in tap water, the content of thalline material is 50 % by weight.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Embodiment 2.8
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
Method according to embodiment 2.1 is tested, different, step (1) is obtained to viable bacteria body hot deactivation 0.5h at 85 DEG C of lactobacillus salivarius A, obtain thalline material, this thalline material is joined in tap water and do not add viable bacteria body, in tap water, the content of thalline material is 30 % by weight.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Embodiment 2.9
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
Method according to embodiment 2.6 is tested, different, and in tap water, the content of thalline material is 65 % by weight.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Embodiment 2.10
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
Method according to embodiment 2.6 is tested, different, and in tap water, the content of thalline material is 15 % by weight.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Embodiment 2.11
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
Method according to embodiment 2.6 is tested, different, and deactivation temperature is 90 DEG C, and inactivation time is 0.3h.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Embodiment 2.12
The present embodiment is for illustrating effect that lactobacillus salivarius of the present invention delays senility.
Method according to embodiment 2.6 is tested, different, and deactivation temperature is 60 DEG C, and inactivation time is 2.0h.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Comparative example 2.1
Method according to embodiment 2.1 is tested, different, with the alternative lactobacillus salivarius A of the disclosed bacterial strain of CN 101538545A.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Comparative example 2.2
Method according to embodiment 2.6 is tested, different, with the alternative lactobacillus salivarius A of the disclosed bacterial strain of CN 101538545A.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Comparative example 2.3
Method according to embodiment 2.1 is tested, different, does not add bacterial classification in tap water.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Comparative example 2.4
Method according to embodiment 2.1 is tested, different, and not injection of d-galactose does not add bacterial classification in tap water.Survey Iipofuscin content, brain MAO-B activity, brain SOD activity and the brain Na of Male Kunming strain mice
+/ K
+-atpase activity, the results are shown in Table 2.
Table 2
The free radical producing in metabolic process can act on the polyunsaturated fatty acid in biological film phospholipid, produce lipid peroxide, as mda (MDA), and then becoming macromolecular complex-lipofuscin (age pigment) with protein cross with phosphatidylethanolamine, this is the one mark of organism aging process.
In human brain, MAO-B activity increased with age growth after 45 years old, Fowier finds that the MAO-B activity in human brain 19 regions was proportionate with the age, in cerebral tissue, MAO-B can cause changes of Catecholamine Content disorder in brain with the variation at age, impels physiological activity imbalance, thereby causes old and feeble generation.
SOD is oxygen radical removing enzyme in the important body of a class, but with age growth, the SOD activity in body tissue lowers gradually.
Na
+/ K
+-ATP enzyme claims again sodium [potassium, is a kind of very important film enzyme extensively existing in organism, and this enzyme plays an important role in ionic equilibrium inside and outside maintaining physiological activity, body temperature and eubolism and cytolemma.When biological decay, there will be multiple biochemical variation, wherein the variation of function of brain cell is more obvious, and this may reduce relevant with brain cell energy.There is report, its Na in some tissues of old rats
+/ K
+the younger mouse of-atpase activity decreases.
Comparative example 2.3 and comparative example 2.4 are compared and can be found out, injection of d-galactose after eyeball of mouse, can accelerate the aging of mouse.Embodiment 2.1 to embodiment 2.12 is compared and can be found out with comparative example 2.3, and lactobacillus salivarius of the present invention has the effect delaying senility; Embodiment 2.1 is compared with comparative example 2.1, embodiment 2.6 is compared and can be found out with comparative example 2.2, lactobacillus salivarius of the present invention has than the disclosed bacterial strain of CN 101538545A the effect delaying senility more significantly.
Embodiment 2.1 is compared and can be found out with embodiment 2.4 and embodiment 2.5 respectively, and in tap water, the content of the viable bacteria body of lactobacillus salivarius is 10
7-10
9cFU/g, is more conducive to delay senility; Embodiment 2.6 is compared and can be found out with embodiment 2.9 and embodiment 2.10 respectively, and the content of the thalline material obtaining after the viable bacteria body deactivation of lactobacillus salivarius in tap water is 30-50 % by weight, is more conducive to delay senility; Embodiment 2.6 is compared and can be found out with embodiment 2.11 and embodiment 2.12 respectively, at 65-85 DEG C of deactivation 0.5-1.5h, be more conducive to delay senility.
Thalline material after viable bacteria body and the deactivation of lactobacillus salivarius provided by the invention all has the effect delaying senility.
Claims (10)
1. a lactobacillus salivarius (Lactobacillus salivarius), is characterized in that, the deposit number of described lactobacillus salivarius is CGMCC No.6288.
2. prepare a method for functional food composition, described method comprises: by the viable bacteria body deactivation of lactobacillus salivarius claimed in claim 1, obtain thalline material.
3. method according to claim 2, wherein, the condition of described deactivation comprises: temperature is 65-85 DEG C, the time is 0.5-1.5h.
4. according to the method in claim 2 or 3, wherein, described method also comprises, described thalline material is added in food.
5. method according to claim 4, wherein, taking the gross weight of described functional food composition as benchmark, the addition of described thalline material is 10-70 % by weight, is preferably 30-50 % by weight.
6. a functional food composition of being prepared by the method described in any one in claim 2-5.
7. a functional food composition, is characterized in that, the viable bacteria body that described functional food composition contains lactobacillus salivarius claimed in claim 1.
8. functional food composition according to claim 7, wherein, taking the gross weight of described functional food composition as benchmark, the content of the viable bacteria body of described lactobacillus salivarius is 10
5-10
10cFU/g, is preferably 10
7-10
9cFU/g.
9. according to the functional food composition described in claim 7 or 8, wherein, described functional food composition also contains food.
10. the application in the functional food composition that lactobacillus salivarius claimed in claim 1 delays senility in preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210572842.5A CN103897998B (en) | 2012-12-25 | 2012-12-25 | Lactobacillus salivarius and application and functional food composition and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210572842.5A CN103897998B (en) | 2012-12-25 | 2012-12-25 | Lactobacillus salivarius and application and functional food composition and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103897998A true CN103897998A (en) | 2014-07-02 |
| CN103897998B CN103897998B (en) | 2016-06-29 |
Family
ID=50989577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210572842.5A Active CN103897998B (en) | 2012-12-25 | 2012-12-25 | Lactobacillus salivarius and application and functional food composition and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103897998B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105395575A (en) * | 2015-11-19 | 2016-03-16 | 徐州一统食品工业有限公司 | Chewable tablet containing inactivated lactobacillus salivarius and preparation method thereof |
| CN110923172A (en) * | 2019-12-25 | 2020-03-27 | 汉臣氏（沈阳）儿童制品有限公司 | Lactobacillus salivarius with constipation relieving and cholesterol reducing effects and application thereof |
| CN111297914A (en) * | 2020-02-24 | 2020-06-19 | 北京农学院 | Application of lactobacillus fermentation clear liquid in antioxidation or preparation of product for antioxidation and antioxidation product |
| CN114558037A (en) * | 2022-02-24 | 2022-05-31 | 同济大学 | Application of AKK and LS in preparation of anti-aging product for improving cognition level |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007007989A1 (en) * | 2005-07-07 | 2007-01-18 | Doosan Corporation | Lactic acid bacteria culture of mung bean and the preparation method of the same, and the cosmetic composition comprising the same |
| CN101538545B (en) * | 2009-04-08 | 2011-07-20 | 任发政 | Lactobacillus salivarius and food composition thereof |
| EP2392340A1 (en) * | 2010-06-01 | 2011-12-07 | GenMont Biotech Inc. | Novel lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof |
| WO2012107601A1 (en) * | 2011-02-09 | 2012-08-16 | De Las Heras Del Rio Jose Miguel | Use of a strain of lactobacillus bulgaricus for treating immunosenescence |
-
2012
- 2012-12-25 CN CN201210572842.5A patent/CN103897998B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007007989A1 (en) * | 2005-07-07 | 2007-01-18 | Doosan Corporation | Lactic acid bacteria culture of mung bean and the preparation method of the same, and the cosmetic composition comprising the same |
| CN101538545B (en) * | 2009-04-08 | 2011-07-20 | 任发政 | Lactobacillus salivarius and food composition thereof |
| EP2392340A1 (en) * | 2010-06-01 | 2011-12-07 | GenMont Biotech Inc. | Novel lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof |
| WO2012107601A1 (en) * | 2011-02-09 | 2012-08-16 | De Las Heras Del Rio Jose Miguel | Use of a strain of lactobacillus bulgaricus for treating immunosenescence |
Non-Patent Citations (3)
| Title |
|---|
| JIN LEE ET AL.: "Evaluation of probiotic characteristics of newly isolated Lactobacillus spp.:Immune modulation and longevity", 《INTERNATIONAL OF FOOD MICROBIOLOGY》 * |
| 王芳 等: "利用SOS显色反应评价长寿老人源乳酸菌对4-NQO基因毒性的抑制作用", 《食品科学》 * |
| 陈晓峰: "Lactobacillus. salivarrius FBC05益生特性的研究", 《中国优秀硕士学位论文数据库》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105395575A (en) * | 2015-11-19 | 2016-03-16 | 徐州一统食品工业有限公司 | Chewable tablet containing inactivated lactobacillus salivarius and preparation method thereof |
| CN110923172A (en) * | 2019-12-25 | 2020-03-27 | 汉臣氏（沈阳）儿童制品有限公司 | Lactobacillus salivarius with constipation relieving and cholesterol reducing effects and application thereof |
| CN110923172B (en) * | 2019-12-25 | 2023-05-09 | 江西仁仁健康微生态科技有限公司 | Lactobacillus salivarius with bowel relaxing effect and cholesterol reducing effect and application thereof |
| CN111297914A (en) * | 2020-02-24 | 2020-06-19 | 北京农学院 | Application of lactobacillus fermentation clear liquid in antioxidation or preparation of product for antioxidation and antioxidation product |
| CN114558037A (en) * | 2022-02-24 | 2022-05-31 | 同济大学 | Application of AKK and LS in preparation of anti-aging product for improving cognition level |
| CN114558037B (en) * | 2022-02-24 | 2023-08-15 | 同济大学 | Application of AKK and LS in preparation of anti-aging products for improving cognition level |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103897998B (en) | 2016-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102229889B (en) | Chlorella, its culture method and applications | |
| Damare et al. | Fungi and macroaggregation in deep-sea sediments | |
| Mohamed | Toxic cyanobacteria and cyanotoxins in public hot springs in Saudi Arabia | |
| CN101263221B (en) | Liquid media for chlamydospore production of the fungus pochonia chlamydsporia | |
| CN103555624B (en) | One strain fixed nitrogen Bacillus licheniformis and uses thereof | |
| CN110438028A (en) | A kind of people pig source Bei Laisi bacillus GX-1 of degraded cellulose | |
| CN110079476A (en) | One plant of lactobacillus fermenti that can reduce blood uric acid | |
| CN110184209A (en) | One plant of Lactobacillus rhamnosus that can reduce blood uric acid | |
| CN101402923A (en) | Plant lactobacillus M1-UVs29 and uses thereof | |
| CN103897998A (en) | Lactobacillus salivarius, applications thereof, functional food compositions and preparation method of the functional food composition | |
| CN109722388A (en) | Microalgae commensalism bacterium isolation medium, separation method and the crucial bacterium high-throughput screening method for influencing micro algae growth | |
| CN105925503B (en) | One plant of salt tolerant rhizosphere growth-promoting enterobacter cloacae and its application | |
| RU2482179C1 (en) | Bacillus atropheus BACTERIA STRAIN - OIL AND OIL PRODUCT DECOMPOSER | |
| TWI537388B (en) | Using high yield mutant strain of bacillus subtilis ssp. and semi-solid state fermentation method to produce surfactin. | |
| CN105925493B (en) | One plant of bamboo parasitic fungus and its application in fermenting and producing hypocrellin | |
| CN104046573A (en) | Bifidobacteria longum and application thereof, and functional food composition and preparation method thereof | |
| WO2012058835A1 (en) | Bacillus subtilis strain with phosphorus-decomposing ability and application thereof | |
| Simandjuntak et al. | Isolation and identification of thermophilic bacteria, producer of amylase enzyme, from Lake Linow, North Sulawesi | |
| Sallenave et al. | Bioaccumulation of mycotoxins by shellfish: contamination of mussels by metabolites of a Trichoderma koningii strain isolated in the marine environment | |
| Dong et al. | Enhanced biomass production and wastewater treatment in attached co-culture of Chlorella pyrenoidosa with nitrogen-fixing bacteria Azotobacter beijerinckii | |
| Zhang et al. | Citricoccus lacusdiani sp. nov., an actinobacterium promoting Microcystis growth with limited soluble phosphorus | |
| Huang et al. | Screening of flocculant-producing strains by NTG mutagenesis | |
| CN101805714B (en) | Hexachloro cyclohexane degrading bacteria and application thereof in degraded hexachloro cyclohexane | |
| CN105935108A (en) | Prawn feed additive containing Rhodobacter Capsulatus and Bacillus subtilis strains, and application thereof | |
| CN104130949B (en) | A kind of the liquid deep layer fermenting culture medium and cultural method of rich iron Cordyceps militaris |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20161031 Address after: 100083 Haidian District Qinghua East Road, No. 17, Beijing Patentee after: China Agricultural University Address before: 100085, room 5, building 39, No. 203 West Road, Beijing, Haidian District Patentee before: Beijing Zhongtian Shenzhou Space Foods Technology Research Institute |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170418 Address after: 610000 Tianfu Square, Tianfu Square, hi tech Zone, Sichuan, Chengdu, China T3-35 Patentee after: TIBET TREASURE OF PLATEAU YAK DAIRY INDUSTRY CO., LTD. Address before: 100083 Haidian District Qinghua East Road, No. 17, Beijing Patentee before: China Agricultural University |
|
| CP02 | Change in the address of a patent holder | ||
| CP02 | Change in the address of a patent holder |
Address after: 851400 A in Tibet District of Lhasa economic and Technological Development Zone Qionggang Lin Road East Road No. 6 Patentee after: TIBET TREASURE OF PLATEAU YAK DAIRY INDUSTRY CO., LTD. Address before: 610000 Tianfu Square, Tianfu Square, hi tech Zone, Sichuan, Chengdu, China T3-35 Patentee before: TIBET TREASURE OF PLATEAU YAK DAIRY INDUSTRY CO., LTD. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20211014 Address after: 851400 No. 6, East 1st Road, linqionggang Road, zone a, Lhasa Economic and Technological Development Zone, Lhasa City, Tibet Autonomous Region Patentee after: TIBET TREASURE OF PLATEAU YAK DAIRY INDUSTRY Co.,Ltd. Patentee after: QINGHAI TREASURE OF PLATEAU YAK MILK Co.,Ltd. Patentee after: RUOERBAO TREASURE OF PLATEAU YAK MILK Co.,Ltd. Address before: 851400 No.6, East 1st Road, linqionggang Road, zone a, Lhasa Economic and Technological Development Zone, Tibet Patentee before: TIBET TREASURE OF PLATEAU YAK DAIRY INDUSTRY Co.,Ltd. |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: 851400 No. 6, East 1st Road, linqionggang Road, zone a, Lhasa Economic and Technological Development Zone, Lhasa City, Tibet Autonomous Region Patentee after: TIBET TREASURE OF PLATEAU YAK DAIRY INDUSTRY Co.,Ltd. Patentee after: QINGHAI TREASURE OF PLATEAU YAK MILK CO.,LTD. Patentee after: Ruoergai Plateau Zhibao yak milk nutritional food Co.,Ltd. Address before: 851400 No. 6, East 1st Road, linqionggang Road, zone a, Lhasa Economic and Technological Development Zone, Lhasa City, Tibet Autonomous Region Patentee before: TIBET TREASURE OF PLATEAU YAK DAIRY INDUSTRY Co.,Ltd. Patentee before: QINGHAI TREASURE OF PLATEAU YAK MILK CO.,LTD. Patentee before: RUOERBAO TREASURE OF PLATEAU YAK MILK CO.,LTD. |